China Medipharm Insights - March 2000


USD 1,000.00

* Required Fields

USD 1,000.00


Be the first to review this product

Table of Contents

China Medipharm Insights - March 2000, China Medipharm InsightsDRUG CONSUMPTIONHospital Drug Consumption Analysis in the First Half of 1999Product NewsTwo New Preparations To Be Launched By Xinhua PharmKanglaite Injections Inhibit VascularizationNew Anti-Cancer Drug Passed EvaluationNew Anticancer Vaccine Developed In BeijingNew Anti-Cancer Drug Senyi Capsule MarketedAIDS Virus Diagnostic Reagent Passes EvaluationHigh Purity Rh-EGF MarketedAzithromycin Injections Marketed In HangzhouGenetically Engineered Hepatitis B Vaccine ExportedMarket AnalysisDrug Market Changes in Beijing in 1999Company ProfilesLixin Pharm of Livzon Group Booming Pharma Technological Park Laid Foundation In WuhanHebei Pharm Factory ThrivingAstraZeneca China Website OpenedXi’an Lijun Pharm EstablishedBaiyunshan TCM Reports Large Increase In Export Of Anti-Flu Drugs Hisun Group Listed As National Key EnterprisesShandong Qilu Pharm Striving For ResplendenceAirback Acquires Hubei Exi ChemicalXinhua Lukang Taking Advantages Of the MergerSouthwest Pharm Saw Steady Growth In 1999Dutch Nutricia (Wuxi) EstablishedNatural Drug Technology Center Set Up at Yantai LuyeShanghai Medicines Group Moving ForwardChina Medical Guangzhou Branch Reached New HighFuxing Pharm Signs Agreement With Lianhua SupermarketShenyang No.1 Pharm Broke Records in Economic ReturnsConba Group Recorded Rapid DevelopmentHeraeus-Kulzer Dental Ltd Sets Foot in ShanghaiYingte Pharm Saw Rapid Growth in SalesRegulationsDrug Registration Procedures Issued by SDAProduct AnalysisCefazolin Market AnalysisLocal NewsZhenjiang Readjust Medical Health Care Insurance SchemeBeijing Drug Administration Opened UpSurvival Rate Of Cancer Patients Rose In BeijingBiotechnology And Pharmaceutical Industries Listed As Key Industries In Shandong2000 Goal for the Pharmaceutical IndustryYunnan Quickens Its Development In Pharmaceutical IndustryJiangxi Acquired Outstanding Achievement In Pharmaceutical IndustryPharmaceutical Industry Saw Development In WuhanGuangdong Pharmaceutical Industry FlourishingNews in BriefDrug Administrative Licenses ExtendedMedical Insurance System Reform Still Facing DifficultiesHealth System Reform Starts OutLaw on Administration of Medical Instruments and Devices PromulgatedChina Biological Product Standards And Regulations ApprovedChina Chemical/Pharmaceutical Industrial Association Pricing Committee EstablishedOne Fourth Of China’s Population Expects To Enter Old Age In Mid-21 CenturyLow Incidence Of CCR5 Mutation In The Chinese PopulationLactic Acid Reduction Can Lead To Vaginosis2000 National Drug Inspection Programs Start

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.